Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
127.29
+1.10 (+0.87%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
47
48
Next >
Morgan Stanley, Abbott Laboratories And 3 Stocks To Watch Heading Into Wednesday
October 16, 2024
Via
Benzinga
A Glimpse of Abbott Laboratories's Earnings Potential
October 15, 2024
Via
Benzinga
Beyond The Numbers: 9 Analysts Discuss Abbott Laboratories Stock
October 14, 2024
Via
Benzinga
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
October 14, 2024
Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana.
Via
Talk Markets
Columbus Day: Is Stock Market Open Today?
October 14, 2024
Investors should brace for a busy week with earnings reports from major companies.
Via
Benzinga
Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth
October 08, 2024
Abbott Laboratories' MedTech portfolio currently contributes around 45% of total sales of about $42 billion.
Via
Benzinga
A Look Into Abbott Laboratories Inc's Price Over Earnings
October 08, 2024
Via
Benzinga
How Is The Market Feeling About Abbott Laboratories?
October 07, 2024
Via
Benzinga
Navigating 6 Analyst Ratings For Abbott Laboratories
September 26, 2024
Via
Benzinga
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
October 08, 2024
Via
Benzinga
3 Magnificent Dividend Stocks to Buy in October
October 06, 2024
These dividend stocks are great picks as the fall season gets underway.
Via
The Motley Fool
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
October 05, 2024
Investors can find market-trouncing blue chip stocks in the healthcare industry.
Via
The Motley Fool
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
October 03, 2024
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.
Via
Investor's Business Daily
Topics
Stocks
Down More Than 50%, Is DexCom Stock a Bargain Now?
October 02, 2024
Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market.
Via
The Motley Fool
Why ABBOTT LABORATORIES (NYSE:ABT) should be investigated by quality investors.
September 11, 2024
Is ABBOTT LABORATORIES (NYSE:ABT) a Strong Candidate for Quality Investing?
Via
Chartmill
2 Excellent Dividend Stocks to Buy With Less Than $200
September 28, 2024
Abbott Laboratories and Johnson & Johnson both have raised their dividends annually for more than 50 years.
Via
The Motley Fool
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
September 25, 2024
These dividend players could lift your portfolio no matter what the market is doing.
Via
The Motley Fool
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
September 19, 2024
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation.
Via
Benzinga
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
September 19, 2024
Via
Benzinga
20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates
September 18, 2024
Investors are anticipating the first cut to the federal funds rate in over four years at the September FOMC meeting. The market is divided on the magnitude of the cut, which could trigger significant...
Via
Benzinga
Topics
Economy
Stocks
Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns
September 17, 2024
These reliable dividend stocks are great buys, with shares still near the bottom of long-term ranges and accelerating growth expected in 2025.
Via
MarketBeat
Topics
Economy
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
September 16, 2024
The dividend growth powerhouse is turning the corner.
Via
The Motley Fool
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
September 16, 2024
The company continues to flex its innovative muscles.
Via
The Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
These stocks are built for the long run.
Via
The Motley Fool
3 Ultra-Safe Dividend Stocks for Retirees to Buy and Hold
September 13, 2024
These stocks have increased their payouts for decades.
Via
The Motley Fool
2 Stocks That Are Passive Income Machines to Buy and Hold Forever
September 11, 2024
You can take these dividends straight to the bank.
Via
The Motley Fool
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
September 09, 2024
Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases
Via
MarketBeat
Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System
September 05, 2024
Abbott recalls some FreeStyle Libre 3 sensors due to incorrect glucose readings, risking severe health issues.
Via
Benzinga
Topics
Product Recall
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
September 05, 2024
The companies are now duking it out for a new population of CGM users.
Via
Investor's Business Daily
Patchy But Still Bullish
September 02, 2024
Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations.
Via
Talk Markets
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
47
48
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.